Priority Date: 07.07.09 (US 20090223684P)

Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy

  • Application ID: EP14168117
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorneys

operating since 1927
Headquarter in Munich
active in Legal Services
Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1307.46
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Jones Day is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 229 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 07.07.2009 - Priority Date (US 20090223684P)
  • 28.09.2016 - Publication A1 (EP3072890)
  • 17.10.2018 - Publication B1 (EP3072890)